Your shopping cart is currently empty

L-Cysteinesulfinic acid is an endogenous neurotransmitter with agonistic effects on a variety of metabotropic glutamate receptors (mGluRs), including mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, with a pEC50 = 2.7 to 4.0. L- Cysteinesulfinic acid is a pld-coupled agonist of metabotropic excitatory amino acid (EAA) receptors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $30 | In Stock | In Stock | |
| 10 mg | $48 | In Stock | In Stock | |
| 25 mg | $98 | In Stock | In Stock | |
| 50 mg | $143 | In Stock | In Stock | |
| 100 mg | $209 | - | In Stock | |
| 200 mg | $313 | - | In Stock |
| Description | L-Cysteinesulfinic acid is an endogenous neurotransmitter with agonistic effects on a variety of metabotropic glutamate receptors (mGluRs), including mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, with a pEC50 = 2.7 to 4.0. L- Cysteinesulfinic acid is a pld-coupled agonist of metabotropic excitatory amino acid (EAA) receptors. |
| Targets&IC50 | mGluR2:3.9 (pEC50), mGluR6:4.0 (pEC50), mGluR5:4.6 (pEC50), mGluR8:3.94 (pEC50), mGluR4:2.7 (pEC50), mGluR1:3.92 (pEC50) |
| In vitro | CHO cells expressing mGluR1, mGluR5, and mGluR8 were treated with L-Cysteinesulfinic acid (L-CSA) for 45 minutes at 37°C, and receptor activation was assessed by measuring [³H]-inositol phosphate accumulation. The results showed that L-CSA activated mGluR1 and mGluR5, inducing IP formation with lower potency than L-glutamate but with significant activity. In cells expressing mGluR2, mGluR4, and mGluR6, L-CSA inhibited forskolin-induced cAMP production, indicating activation of these Gi/o-coupled receptors via inhibition of adenylyl cyclase [1]. |
| Molecular Weight | 153.16 |
| Formula | C3H7NO4S |
| Cas No. | 1115-65-7 |
| Smiles | [C@H](CS(=O)O)(C(O)=O)N |
| Relative Density. | 1.828 g/cm3 (Predicted) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 110 mg/mL (718.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.